|
TOP1P1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.795600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.914600E-01 |
| Normal-vs-Stage2 |
9.071900E-02 |
| Normal-vs-Stage3 |
4.643200E-01 |
| Normal-vs-Stage4 |
9.243600E-01 |
| Stage1-vs-Stage2 |
2.246000E-01 |
| Stage1-vs-Stage3 |
8.345000E-01 |
| Stage1-vs-Stage4 |
4.856000E-01 |
| Stage2-vs-Stage3 |
3.566800E-01 |
| Stage2-vs-Stage4 |
8.999800E-02 |
| Stage3-vs-Stage4 |
4.529600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.474400E-01 |
| Normal-vs-AfricanAmerican |
6.477800E-01 |
| Normal-vs-Asian |
3.254800E-01 |
| Caucasian-vs-AfricanAmerican |
2.220600E-01 |
| Caucasian-vs-Asian |
1.149380E-01 |
| AfricanAmerican-vs-Asian |
3.487400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.356300E-02 |
| Normal-vs-Female |
2.172800E-01 |
| Male-vs-Female |
6.394800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.399890E-02 |
| Normal-vs-Age(41-60Yrs) |
9.361600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.370200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.615200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.348300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.204630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.265200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.748440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.216200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.689800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.583400E-01 |
| Normal-vs-Grade 2 |
9.809400E-01 |
| Normal-vs-Grade 3 |
2.653200E-01 |
| Normal-vs-Grade 4 |
1.684200E-01 |
| Grade 1-vs-Grade 2 |
3.312800E-01 |
| Grade 1-vs-Grade 3 |
1.050630E-01 |
| Grade 1-vs-Grade 4 |
7.932200E-02 |
| Grade 2-vs-Grade 3 |
2.812600E-01 |
| Grade 2-vs-Grade 4 |
1.768770E-01 |
| Grade 3-vs-Grade 4 |
5.621200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.055400E-01 |
| Normal-vs-ccB subtype |
9.412500E-02 |
| ccA subtype-vs-ccB subtype |
4.042000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.054200E-01 |
| Normal-vs-N1 |
8.645200E-01 |
| N0-vs-N1 |
8.912600E-01 |
|
|
